In order to quickly move forward on a war funding bill, the US Senate has dropped a number of amendments, including an amendment sent by the House of Representatives that pertained to a "pay-for-delay" ban 1 . Although pharma has gained a reprieve ...
Vince Postill compares two anti-counterfeiting technologies and explains why mass serialisation may be the better solution. Whilst patients may be unaware about the true risk of drug counterfeiting, the pharmaceutical industry is far from ...
China and Taiwan have signed a wide-ranging bilateral agreement on the protection of intellectual property rights, which lays down major principles with implications for many products, including pharmaceuticals 1 . The Cross-Strait Agreement on IPR ...
The US Justice Department?s solicitor general has filed an amicus brief urging the Supreme Court to deny Pfizer ?s petition for review of a January 2009 federal appeals court ruling reinstating claims in actions brought by more than 80 Nigerian ...
The US Supreme Court is asking for the Obama Administration?s views on whether a generic drug company can face state-based, failure-to-warn claims for product labelling that mirrors the reference listed drug 1 . The court?s 24 May request that the ...
The European Commission has accused pharmaceutical company Servier of submitting "misleading and incorrect information" in response to a competition sector inquiry 1 ,2 . The commission has sent Servier a "statement of objections", claiming that it ...
